Skip to content
Peptide.Guide

Weekly digest

This week in peptides.

29 stories broke across the peptide world this week, led by coverage of Semaglutide, NAD+ and Retatrutide. Reporting from Reuters, Open Magazine, Bioengineer.org, ΕΜΥ, and others.

This week

Earlier coverage

fda.gov.ph29d ago

FDA Advisory No.2026-1263 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Tesamorelin 10 mg (Tesamorelin acetate, GHRH analog) Lyophilized Powder for Injection for Subcutaneous Use Only and Bacteriostatic W - fda.gov.ph

FDA Advisory No.2026-1263 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Tesamorelin 10 mg (Tesamorelin acetate, GHRH analog) Lyophilized Powder for Injection for Subcutaneous Use Only and Bacteriostatic W fda.gov.ph

Tesamorelin
Browse the full live news feedGet the digest by email

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.